Article info
PDFConcise report
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study
- Correspondence to:
Professor A A Drosos
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110 Ioannina, Greece; adrosos{at}cc.uoi.gr
Citation
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study
Publication history
- Accepted June 18, 2005
- First published June 23, 2005.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases